Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Photo of Celerino Abad-Zapatero

Celerino Abad-Zapatero


Research Professor, University of Illinois at Chicago

Contact

Office Phone:

(312) 355-4105 (lab)

Email:

caz@uic.edu

About Heading link

Overview:
Macromolecular crystallographer (Proteins/viruses) with more than forty years experience. Over twenty (22) years of experience in Structure-Based Drug Design at Abbott Laboratories. Since Feb. 2007 affiliated with UIC in several capacities (Adjunct Professor, Research Professor, ITR affiliate). Participating actively with senior faculty members in structure biology and drug discovery projects projects in the Department of Medicinal Chemistry and Center for Biomolecular Sciences . Most recently, supporting Structural-Biology and Drug Discovery efforts at the Institute of Tuberculosis Research on targets related to TB therapy.

Research Interests:
Structural Biology and Structure-Based Drug Design. In addition, developing the concepts and applications related to Ligand Efficiency Indices (LEIs) to make drug discovery more efficient. Particularly, the development of the concept of AtlasCBS (Atlas of Chemico-Biological Space).

Teaching Statement:
Guest lecturer for the MDCH562 course covering the basics of X-ray Crystallography with special emphasis on macromolecular (protein) crystallography and its application to drug discovery (Structure-Based Drug Design).
The four lectures were video recorded and are available for future use.

Selected Grants

Engineered enzyme sensors based on allosteric regulation, PharmaSeq, Inc.., 5/1/2019 - 4/30/2021, Obligated Amount: $60000; Anticipated Amount: $60000

Modulation of Protein production and Degradation as an integrated approach to rapid sterilization of Drug sensitive and resistant Mtb, Global Alliance for TB Drug Development., 4/1/2019 - 3/31/2023, Obligated Amount: $7080805; Anticipated Amount: $7080805

High-Throughput Screening and Validation of Inhibitors Against M. Tuberculosis Class II FBPase, Chicago Biomedical Consortium., 10/1/2016 - 3/31/2018, No Obligated Amount Set; No Anticipated Amount Set

High-Throughput Screening and Validation of Inhibitors Against M. Tuberculosis Class II FBPase, Chicago Biomedical Consortium., 10/1/2016 - 3/31/2018, No Obligated Amount Set; No Anticipated Amount Set

MtFBPase (Rv 1099c): A Promising Target for Tuberculosis Chemotherapy, Potts Memorial Fdn., 7/1/2016 - 6/30/2018, No Obligated Amount Set; No Anticipated Amount Set

MtFBPase (Rv 1099c): A Promising Target for Tuberculosis Chemotherapy, Potts Memorial Fdn., 7/1/2016 - 6/30/2018, No Obligated Amount Set; No Anticipated Amount Set

Macromolecular Diffraction Resource: MacCHESS, National Center for Advancing Translational Sciences., 9/1/1983 - 6/30/2013, Obligated Amount: $38908540; No Anticipated Amount Set

Selected Publications

★ Abad-Zapatero, Celerino. (2021). Notes of a protein crystallographer: the legacy of J.‐B. J. Fourier – crystallography, time and beyond. Acta Crystallographica Section D, Structural Biology, 77, (5), 703-711. doi:10.1107/s205979832100293x.

★ Abad-Zapatero, Celerino. (2021). Ligand efficiency indices for effective drug discovery: a unifying vector formulation. Expert Opinion on Drug Discovery, 16, (7), 1-13. doi:10.1080/17460441.2021.1884065.

★ Selezneva, Anna I, Gutka, Hiten J, Wolf, Nina M, Qurratulain, Fnu, Movahedzadeh, Farahnaz, Abad-Zapatero, Celerino. (2020). Structural and biochemical characterization of the class II fructose‐1,6‐bisphosphatase from Francisella tularensis. Acta Crystallographica Section F: Structural Biology Communications, 76, (11), 524-535. doi:10.1107/s2053230x20013370.

★ Cotrina, Ellen Y, Blasi, Daniel, Vilà, Marta, Planas, Antoni, Abad-Zapatero, Cele, Centeno, Nuria B, Quintana, Jordi, Arsequell, Gemma. (2020). Optimization of kinetic stabilizers of tetrameric transthyretin: A prospective ligand efficiency-guided approach. Bioorganic & Medicinal Chemistry, 28, (23), 115794. doi:10.1016/j.bmc.2020.115794.

★ Wolf, Nina M, Lee, Hyun, Zagal, Daniel, Nam, Joo-Won, Oh, Dong-Chan, Lee, Hanki, Suh, Joo-Won, Pauli, Guido F, Cho, Sanghyun, Abad-Zapatero, Celerino. (2020). Structure of the N‐terminal domain of ClpC1 in complex with the antituberculosis natural product ecumicin reveals unique binding interactions. Acta Crystallographica Section D, Structural Biology, 76, (5), 458-471. doi:10.1107/s2059798320004027.

★ Wolf, Nina M, Lee, Hyun, Choules, Mary P, Pauli, Guido F, Phansalkar, Rasika, Anderson, Jeffrey R, Gao, Wei, Ren, Jinhong, Santarsiero, Bernard D, Lee, Hanki, Cheng, Jinhua, Jin, Ying-Yu, Ho, Ngoc Anh, Duc, Nguyen Minh, Suh, Joo-Won, Abad-Zapatero, Celerino, Cho, Sanghyun. (2019). High-Resolution Structure of ClpC1-Rufomycin and Ligand Binding Studies Provide a Framework to Design and Optimize Anti-Tuberculosis Leads. ACS Infectious Diseases, 5, (6), 829-840. doi:10.1021/acsinfecdis.8b00276.

★ Wolf, Nina M, Gutka, Hiten J, Movahedzadeh, Farahnaz, Abad-Zapatero, Celerino. (2018). Structures of the Mycobacterium tuberculosis GlpX protein (class II fructose‐1,6‐bisphosphatase): implications for the active oligomeric state, catalytic mechanism and citrate inhibition. Acta Crystallographica Section D, Structural Biology, 74, (4), 321-331. doi:10.1107/s2059798318002838.

★ Bondoc, Jasper Marc G, Wolf, Nina M, Ndichuck, Michael, Abad-Zapatero, Celerino, Movahedzadeh, Farahnaz. (2017). Mutagenesis of threonine to serine in the active site of Mycobacterium tuberculosis fructose-1,6-bisphosphatase (Class II) retains partial enzyme activity. Biotechnology Reports, 15, 48-54. doi:10.1016/j.btre.2017.06.004.

★ Abad-Zapatero, Celerino. (2016). Are SAR tables obsolete?. Drug Discovery Today, 22, (2), 195-198. doi:10.1016/j.drudis.2016.12.002.

★ Oliete, R, Pous, J, Rodríguez-Puente, S, Abad-Zapatero, C, Guasch, A. (2013). Elastic and inelastic diffraction changes upon variation of the relative humidity environment of PurE crystals. Acta Crystallographica Section D, Structural Biology, 69, (2), 194-212. doi:10.1107/s090744491204454x.

Education

Degrees:
Ph. D., University of Texas, United States, 1978
Licenciado, Universidad de Valladolid, Spain, 1969

Postgraduate Training:
Postdoctoral Associate, Purdue University, United States, 1985